Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Apfalter, P; Boman, J; Nehr, M; Hienerth, H; Makristathis, A; Pauer, J; Thalhammer, F; Willinger, B; Rotter, ML; Hirschl, AM
   Application of blood-based polymerase chain reaction for detection of Chlamydia pneumoniae in acute respiratory tract infections
   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
   
   P. Apfalter et al., "Application of blood-based polymerase chain reaction for detection of Chlamydia pneumoniae in acute respiratory tract infections", EUR J CL M, 20(8), 2001, pp. 584-586
2. Traunmuller, F; Thalhammer-Scherrer, R; Locker, GJ; Losert, H; Schmid, R; Staudinger, T; Thalhammer, F
   Single-dose pharmacokinetics of levofloxacin during continuous veno-venoushaemofiltration in critically ill patients
   Journal of antimicrobial chemotherapy
   
   F. Traunmuller et al., "Single-dose pharmacokinetics of levofloxacin during continuous veno-venoushaemofiltration in critically ill patients", J ANTIMICRO, 47(2), 2001, pp. 229-231
3. Thalhammer, F
   Meropenem and continuous renal replacement
   CRITICAL CARE MEDICINE
   
   F. Thalhammer, "Meropenem and continuous renal replacement", CRIT CARE M, 29(8), 2001, pp. 1653-1654
4. Domenig, C; Traunmuller, F; Kozek, S; Wisser, W; Klepetko, W; Steininger, R; Spiss, C; Thalhammer, F
   Continuous beta-lactam antibiotic therapy in a double-lung transplanted patient with a multidrug-resistant Pseudomonas aeruginosa infection
   TRANSPLANTATION
   
   C. Domenig et al., "Continuous beta-lactam antibiotic therapy in a double-lung transplanted patient with a multidrug-resistant Pseudomonas aeruginosa infection", TRANSPLANT, 71(6), 2001, pp. 744-745
5. Stoiser, B; Looareesuwan, S; Thalhammer, F; Daxbock, F; Chullawichit, S; El-Menyawi, I; Graninger, W; Burgmann, H
   Serum concentrations of granulocyte-colony stimulating factor in complicated Plasmodium falciparum malaria
   EUROPEAN CYTOKINE NETWORK
   
   B. Stoiser et al., "Serum concentrations of granulocyte-colony stimulating factor in complicated Plasmodium falciparum malaria", EUR CYTOKIN, 11(1), 2000, pp. 75-79
6. Stoiser, B; Thalhammer, F; El-Menyawi, I; Wilfing, A; Daxbock, F; Locker, GJ; Burgmann, H
   Homocysteine and laminin are not prognostic markers in patients with septic inflammatory response syndrome
   CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY
   
   B. Stoiser et al., "Homocysteine and laminin are not prognostic markers in patients with septic inflammatory response syndrome", CL DIAG LAB, 7(1), 2000, pp. 119-121
7. Thalhammer, F; Siostrzonek, P
   Cefpirome and continuous venovenous hemofiltration
   INTENSIVE CARE MEDICINE
   
   F. Thalhammer e P. Siostrzonek, "Cefpirome and continuous venovenous hemofiltration", INTEN CAR M, 26(6), 2000, pp. 830-830
8. Thalhammer, F; Horl, WH
   Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy
   CLINICAL PHARMACOKINETICS
   
   F. Thalhammer e W.H. Horl, "Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy", CLIN PHARMA, 39(4), 2000, pp. 271-279
9. Staudinger, T; Stoiser, B; Mullner, M; Locker, GJ; Laczika, K; Knapp, S; Burgmann, H; Wilfing, A; Kofler, J; Thalhammer, F; Frass, M
   Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit
   CRITICAL CARE MEDICINE
   
   T. Staudinger et al., "Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit", CRIT CARE M, 28(5), 2000, pp. 1322-1328
10. Schmaldienst, S; Traunmuller, F; Burgmann, H; Rosenkranz, AR; Thalhammer-Scherrer, R; Horl, WH; Thalhammer, F
    Multiple-dose pharmacokinetics of cefepime in long-term hemodialysis with high-flux membranes
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
    
    S. Schmaldienst et al., "Multiple-dose pharmacokinetics of cefepime in long-term hemodialysis with high-flux membranes", EUR J CL PH, 56(1), 2000, pp. 61-64
11. Banyai, M; Thalhammer, F; El Menyawi, I; Heinz, G; Traunmuller, F; Siostrzonek, P
    Pharmacokinetics of cefpirome during continuous venovenous hemofiltration:Rationale for an 8-hour dosing interval
    CLINICAL PHARMACOLOGY & THERAPEUTICS
    
    M. Banyai et al., "Pharmacokinetics of cefpirome during continuous venovenous hemofiltration:Rationale for an 8-hour dosing interval", CLIN PHARM, 67(4), 2000, pp. 368-372
12. Laczika, K; Thalhammer, F; Locker, G; Apsner, R; Losert, H; Kofler, J; Rabitsch, W; Mares, P; Frass, M; Sunder-Plassmann, G; Muhm, M
    Safe and efficient emergency transvenous ventricular pacing via the right supraclavicular route
    ANESTHESIA AND ANALGESIA
    
    K. Laczika et al., "Safe and efficient emergency transvenous ventricular pacing via the right supraclavicular route", ANESTH ANAL, 90(4), 2000, pp. 784-789
13. Rosenkranz, AR; Kormoczi, GF; Thalhammer, F; Menzel, EJ; Horl, WH; Mayer, G; Zlabinger, GJ
    Novel C5-dependent mechanism of neutrophil stimulation by bioincompatible dialyzer membranes
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
    
    A.R. Rosenkranz et al., "Novel C5-dependent mechanism of neutrophil stimulation by bioincompatible dialyzer membranes", J AM S NEPH, 10(1), 1999, pp. 128-135
14. Thalhammer, F; Traunmuller, F; El Menyawi, I; Frass, M; Hollenstein, UM; Locker, GJ; Stoiser, B; Staudinger, T; Thalhammer-Scherrer, R; Burgmann, H
    Continuous infusion versus intermittent administration of meropenem in critically ill patients
    Journal of antimicrobial chemotherapy
    
    F. Thalhammer et al., "Continuous infusion versus intermittent administration of meropenem in critically ill patients", J ANTIMICRO, 43(4), 1999, pp. 523-527
15. Stoiser, B; Maca, T; Thalhammer, F; Hollenstein, U; El Menyawi, I; Burgmann, H
    Serum nitrate concentrations in patients with peripheral arterial occlusive disease
    VASA-JOURNAL OF VASCULAR DISEASES
    
    B. Stoiser et al., "Serum nitrate concentrations in patients with peripheral arterial occlusive disease", VASA, 28(3), 1999, pp. 181-184
16. Knapp, S; Kofler, J; Stoiser, B; Thalhammer, F; Burgmann, H; Posch, M; Hofbauer, R; Stanzel, M; Frass, M
    The assessment of four different methods to verify tracheal tube placementin the critical care setting
    ANESTHESIA AND ANALGESIA
    
    S. Knapp et al., "The assessment of four different methods to verify tracheal tube placementin the critical care setting", ANESTH ANAL, 88(4), 1999, pp. 766-770
17. ELMENYAWI I; LOOAREESUWAN S; KNAPP S; THALHAMMER F; STOISER B; BURGMANN H
    MEASUREMENT OF SERUM NITRITE NITRATE CONCENTRATIONS USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY/
    Journal of chromatography B. Biomedical sciences and applications
    
    I. Elmenyawi et al., "MEASUREMENT OF SERUM NITRITE NITRATE CONCENTRATIONS USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY/", Journal of chromatography B. Biomedical sciences and applications, 706(2), 1998, pp. 347-351
18. THALHAMMER F; EBERL G; KOPETZKIKOGLER U
    UNUSUAL ROUTE OF TRANSMISSION FOR BRUCELLA-ABORTUS
    Clinical infectious diseases
    
    F. Thalhammer et al., "UNUSUAL ROUTE OF TRANSMISSION FOR BRUCELLA-ABORTUS", Clinical infectious diseases, 26(3), 1998, pp. 763-764
19. THALHAMMER F; HOLLENSTEIN UM; LOCKER GJ; JANATA K; SUNDERPLASSMANN G; FRASS M; BURGMANN H
    AZITHROMYCIN-RELATED TOXIC EFFECTS OF DIGITOXIN
    British journal of clinical pharmacology
    
    F. Thalhammer et al., "AZITHROMYCIN-RELATED TOXIC EFFECTS OF DIGITOXIN", British journal of clinical pharmacology, 45(1), 1998, pp. 91-92
20. HOLLENSTEIN U; THALHAMMER F; BURGMANN H
    DISSEMINATED INTRAVASCULAR COAGULATION (DIC) AND RHABDOMYOLYSIS IN FULMINANT VARICELLA INFECTION - CASE-REPORT AND REVIEW OF THE LITERATURE
    Infection
    
    U. Hollenstein et al., "DISSEMINATED INTRAVASCULAR COAGULATION (DIC) AND RHABDOMYOLYSIS IN FULMINANT VARICELLA INFECTION - CASE-REPORT AND REVIEW OF THE LITERATURE", Infection, 26(5), 1998, pp. 306-308
21. THALHAMMER F; TRAUNMULLER F; BOHMING HJ; DEPISCH D; ILIAS W; HOLLENSTEIN U; SALEM G; WAYAND W; BURGMANN H; BREYER S
    SINGLE-DOSE CEFODIZIME AS INFECTION PROPHYLAXIS IN ABDOMINAL-SURGERY - A PROSPECTIVE MULTICENTER STUDY
    Infection
    
    F. Thalhammer et al., "SINGLE-DOSE CEFODIZIME AS INFECTION PROPHYLAXIS IN ABDOMINAL-SURGERY - A PROSPECTIVE MULTICENTER STUDY", Infection, 26(2), 1998, pp. 136-138
22. THALHAMMER F; KLETZMAYR J; ELMENYAWI I; KOVARIK J; ROSENKRANZ AR; TRAUNMULLER F; HORL WH; BURGMANN H
    OFLOXACIN CLEARANCE DURING HEMODIALYSIS - A COMPARISON OF POLYSULFONEAND CELLULOSE-ACETATE HEMODIALYZERS
    American journal of kidney diseases
    
    F. Thalhammer et al., "OFLOXACIN CLEARANCE DURING HEMODIALYSIS - A COMPARISON OF POLYSULFONEAND CELLULOSE-ACETATE HEMODIALYZERS", American journal of kidney diseases, 32(4), 1998, pp. 642-645
23. KNAPP S; THALHAMMER F; LOCKER GJ; LACZIKA K; HOLLENSTEIN U; FRASS M; WINKLER S; STOISER B; WILFING A; BURGMANN H
    PROGNOSTIC VALUE OF MIP-1-ALPHA, TGF-BETA(2), SELAM-1, AND SVCAM-1 INPATIENTS WITH GRAM-POSITIVE SEPSIS
    Clinical immunology and immunopathology
    
    S. Knapp et al., "PROGNOSTIC VALUE OF MIP-1-ALPHA, TGF-BETA(2), SELAM-1, AND SVCAM-1 INPATIENTS WITH GRAM-POSITIVE SEPSIS", Clinical immunology and immunopathology, 87(2), 1998, pp. 139-144
24. THALHAMMER F; SCHENK P; BURGMANN H; ELMENYAWI I; HOLLENSTEIN UM; ROSENKRANZ AR; SUNDERPLASSMANN G; BREYER S; RATHEISER K
    SINGLE-DOSE PHARMACOKINETICS OF MEROPENEM DURING CONTINUOUS VENOVENOUS HEMOFILTRATION
    Antimicrobial agents and chemotherapy
    
    F. Thalhammer et al., "SINGLE-DOSE PHARMACOKINETICS OF MEROPENEM DURING CONTINUOUS VENOVENOUS HEMOFILTRATION", Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2417-2420
25. STOISER B; THALHAMMER F; CHOTT A; BREYER S; BURGMANN H; GRANINGER W
    A CASE OF VISCERAL LEISHMANIASIS IN AUSTRIA
    Wiener Klinische Wochenschrift
    
    B. Stoiser et al., "A CASE OF VISCERAL LEISHMANIASIS IN AUSTRIA", Wiener Klinische Wochenschrift, 110(9), 1998, pp. 342-345
26. STOISER B; KNAPP S; THALHAMMER F; LOCKER GJ; KOFLER J; HOLLENSTEIN U; STAUDINGER T; WILFING A; FRASS M; BURGMANN H
    TIME-COURSE OF IMMUNOLOGICAL MARKERS IN PATIENTS WITH THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME - EVALUATION OF SCD14, SVCAM-1, SELAM-1, MIP-1-ALPHA AND TGF-BETA-2
    European journal of clinical investigation
    
    B. Stoiser et al., "TIME-COURSE OF IMMUNOLOGICAL MARKERS IN PATIENTS WITH THE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME - EVALUATION OF SCD14, SVCAM-1, SELAM-1, MIP-1-ALPHA AND TGF-BETA-2", European journal of clinical investigation, 28(8), 1998, pp. 672-678
27. Hollenstein, U; Looareesuwan, S; Aichelburg, A; Thalhammer, F; Stoiser, B; Amradee, S; Chullawichit, S; El Menyawi, I; Burgmann, H
    Serum procalcitonin levels in severe Plasmodium falciparum malaria
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
    
    U. Hollenstein et al., "Serum procalcitonin levels in severe Plasmodium falciparum malaria", AM J TROP M, 59(6), 1998, pp. 860-863
28. LACZIKA K; KNAPP S; LOCKER GJ; THALHAMMER F; STOISER B; FRASS M; BURGMANN H
    TREMENDOUS HIGH PLASMA LIPOPOLYSACCHARIDE CONCENTRATIONS IN A PATIENTWITH LEGIONELLA-PNEUMOPHILA PNEUMONIA
    Journal of endotoxin research
    
    K. Laczika et al., "TREMENDOUS HIGH PLASMA LIPOPOLYSACCHARIDE CONCENTRATIONS IN A PATIENTWITH LEGIONELLA-PNEUMOPHILA PNEUMONIA", Journal of endotoxin research, 4(4), 1997, pp. 301-304
29. SUNDERPLASSMANN G; LOCKER GJ; MUHM M; THALHAMMER F; LACZIKA K; VONFRIEDENFELDT MF
    CENTRAL VENOUS CATHETERIZATION IN A PATIENT IN THE PRONE POSITION
    Critical care medicine
    
    G. Sunderplassmann et al., "CENTRAL VENOUS CATHETERIZATION IN A PATIENT IN THE PRONE POSITION", Critical care medicine, 25(8), 1997, pp. 1439-1440
30. FABRIZII V; THALHAMMER F; HORL WH
    AMINOGLYCOSIDE-INDUCED NEPHROTOXICITY
    Wiener Klinische Wochenschrift
    
    V. Fabrizii et al., "AMINOGLYCOSIDE-INDUCED NEPHROTOXICITY", Wiener Klinische Wochenschrift, 109(21), 1997, pp. 830-835
31. THALHAMMER F; ROSENKRANZ AR; BURGMANN H; GRANINGER W; HOLLENSTIEN U; SCHENK P; THALHAMMERSCHERRER R; TRAINDL O; HORL WH; BREYER S
    SINGLE-DOSE PHARMACOKINETICS OF TEICOPLANIN DURING HEMODIALYSIS THERAPY USING HIGH-FLUX POLYSULFONE MEMBRANES
    Wiener Klinische Wochenschrift
    
    F. Thalhammer et al., "SINGLE-DOSE PHARMACOKINETICS OF TEICOPLANIN DURING HEMODIALYSIS THERAPY USING HIGH-FLUX POLYSULFONE MEMBRANES", Wiener Klinische Wochenschrift, 109(10), 1997, pp. 362-365
32. SPERR WR; PIRIBAUER M; AGIS H; MITTERBAUER M; GEISSLER K; HAAS O; FONATSCH C; JAGER U; SCHWARZINGER I; THALHAMMER F; VALENT P; LECHNER K
    INTERMITTENT INTERMEDIATE-DOSE ARA-C AS CONSOLIDATION THERAPY FOR AMLIN THE ELDERLY
    Blood
    
    W.R. Sperr et al., "INTERMITTENT INTERMEDIATE-DOSE ARA-C AS CONSOLIDATION THERAPY FOR AMLIN THE ELDERLY", Blood, 90(10), 1997, pp. 2267-2267
33. FRASS M; KOFLER J; THALHAMMER F; STAUDINGER T; DIELACHER C; KRAFFT P; ILIAS W; HUPFL M; OVASSAPIAN A
    CLINICAL-EVALUATION OF A NEW VISUALIZED ENDOTRACHEAL-TUBE (VETT)
    Anesthesiology
    
    M. Frass et al., "CLINICAL-EVALUATION OF A NEW VISUALIZED ENDOTRACHEAL-TUBE (VETT)", Anesthesiology, 87(5), 1997, pp. 1262-1263
34. THALHAMMER F; HOLLENSTEIN U; JANATA K; KNAPP S; KOLLER R; LOCKER GJ; STAUDINGER T; SUNDERPLASSMANN G; FRASS M; BURGMANN H
    A COINCIDENCE OF DISASTROUS ACCIDENTS - CROHNS-DISEASE, AGRANULOCYTOSIS, AND CLOSTRIDIUM-SEPTICUM INFECTION
    The journal of trauma, injury, infection, and critical care
    
    F. Thalhammer et al., "A COINCIDENCE OF DISASTROUS ACCIDENTS - CROHNS-DISEASE, AGRANULOCYTOSIS, AND CLOSTRIDIUM-SEPTICUM INFECTION", The journal of trauma, injury, infection, and critical care, 43(3), 1997, pp. 556-557
35. THALHAMMER F; SCHENK P; GRANINGER W; HOLLENSTEIN U; ELMENYAWI I; ROSENKRANZ AR; WINTER W; BREYER S; RATHEISER K
    PHARMACOKINETICS OF MEROPENEM DURING CONTINUOUS VENOVENOUS HEMOFILTRATION
    Journal of the American Society of Nephrology
    
    F. Thalhammer et al., "PHARMACOKINETICS OF MEROPENEM DURING CONTINUOUS VENOVENOUS HEMOFILTRATION", Journal of the American Society of Nephrology, 7(9), 1996, pp. 1088-1088
36. THALHAMMER F; SCHMALDIENST S; BURGMANN H; ELMENYAWI I; HOLLENSTEIN U; ROSENKRANZ AR; MAYER G; BREYER S
    CEFPIROME IN CHRONIC-HEMODIALYSIS PATIENTS
    Journal of the American Society of Nephrology
    
    F. Thalhammer et al., "CEFPIROME IN CHRONIC-HEMODIALYSIS PATIENTS", Journal of the American Society of Nephrology, 7(9), 1996, pp. 1089-1089
37. ROSENKRANZ AR; KORMOCZI GF; THALHAMMER F; MAYER G; ZLABINGER GJ
    CELL-SURFACE RECEPTOR MODULATION ON NEUTROPHILS (PMN) DURING HEMODIALYSIS (HD) IS DEPENDENT ON COMPLEMENT COMPONENT C5
    Journal of the American Society of Nephrology
    
    A.R. Rosenkranz et al., "CELL-SURFACE RECEPTOR MODULATION ON NEUTROPHILS (PMN) DURING HEMODIALYSIS (HD) IS DEPENDENT ON COMPLEMENT COMPONENT C5", Journal of the American Society of Nephrology, 7(9), 1996, pp. 2668-2668
38. THALHAMMER F; GEISSLER K; JAGER U; KYRLE PA; PABINGER I; MITTERBAUER M; GISSLINGER H; KNOBL P; LACZIKA K; SCHNEIDER B; HAAS OA; LECHNER K
    DURATION OF 2ND COMPLETE REMISSION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH CHEMOTHERAPY - A RETROSPECTIVE SINGLE-CENTER STUDY
    Annals of hematology
    
    F. Thalhammer et al., "DURATION OF 2ND COMPLETE REMISSION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH CHEMOTHERAPY - A RETROSPECTIVE SINGLE-CENTER STUDY", Annals of hematology, 72(4), 1996, pp. 216-222
39. HOLLENSTEIN U; THALHAMMER F; BURGMANN H; BREYER S
    INFECTIOUS COMPLICATIONS OF IMPLANTABLE C ARDIOVERTER DEFIBRILLATORS - CASE-REPORT AND LITERATURE-REVIEW/
    Acta medica austriaca
    
    U. Hollenstein et al., "INFECTIOUS COMPLICATIONS OF IMPLANTABLE C ARDIOVERTER DEFIBRILLATORS - CASE-REPORT AND LITERATURE-REVIEW/", Acta medica austriaca, 23(5), 1996, pp. 164-167
40. BURGMANN H; WINKLER S; LOCKER GJ; PRESTERL E; LACZIKA K; STAUDINGER T; KNAPP S; THALHAMMER F; WENISCH C; ZEDWITZLIEBENSTEIN K; FRASS M; GRANINGER W
    INCREASED SERUM CONCENTRATION OF SOLUBLE CD14 IS A PROGNOSTIC MARKER IN GRAM-POSITIVE SEPSIS
    Clinical immunology and immunopathology
    
    H. Burgmann et al., "INCREASED SERUM CONCENTRATION OF SOLUBLE CD14 IS A PROGNOSTIC MARKER IN GRAM-POSITIVE SEPSIS", Clinical immunology and immunopathology, 80(3), 1996, pp. 307-310
41. THALHAMMER F; SCHMALDIENST S; ELMENYAWI I; ATTENEDER M; BURGMANN H; HOLLENSTEIN U; GEORGOPOULOS A; GRANINGER W; PUTZ D; ROSENKRANZ AR; MAYER G; HORL WH; BREYER S
    MULTIPLE-DOSE PHARMACOKINETICS OF CEFPIROME IN LONG-TERM HEMODIALYSISWITH HIGH-FLUX MEMBRANES
    Clinical pharmacology and therapeutics
    
    F. Thalhammer et al., "MULTIPLE-DOSE PHARMACOKINETICS OF CEFPIROME IN LONG-TERM HEMODIALYSISWITH HIGH-FLUX MEMBRANES", Clinical pharmacology and therapeutics, 60(6), 1996, pp. 645-650
42. WENISCH C; WENISCH H; PARSCHALK B; VANIJANONTA S; BURGAMANN H; EXNER M; ZEDWITZLIEBENSTEIN K; THALHAMMER F; GEORGOPOULOS A
    ELEVATED LEVELS OF SOLUBLE CD14 IN SERUM OF PATIENTS WITH ACUTE PLASMODIUM-FALCIPARUM MALARIA
    Clinical and experimental immunology
    
    C. Wenisch et al., "ELEVATED LEVELS OF SOLUBLE CD14 IN SERUM OF PATIENTS WITH ACUTE PLASMODIUM-FALCIPARUM MALARIA", Clinical and experimental immunology, 105(1), 1996, pp. 74-78
43. PRADA J; GRANINGER W; LEHMAN LG; METZGER W; NEIFER S; ZOTTER GM; THALHAMMER F; BIENZLE U; KREMSNER PG
    UP-REGULATION OF ICAM-1, IL-1 AND REACTIVE OXYGEN INTERMEDIATES (ROI)BY EXOGENOUS ANTIGENS FROM PLASMODIUM-FALCIPARUM PARASITES IN-VITRO, AND OF SICAM-1 IN THE ACUTE-PHASE OF MALARIA
    Journal of chemotherapy
    
    J. Prada et al., "UP-REGULATION OF ICAM-1, IL-1 AND REACTIVE OXYGEN INTERMEDIATES (ROI)BY EXOGENOUS ANTIGENS FROM PLASMODIUM-FALCIPARUM PARASITES IN-VITRO, AND OF SICAM-1 IN THE ACUTE-PHASE OF MALARIA", Journal of chemotherapy, 7(5), 1995, pp. 424-426
44. BURGMANN H; HOLLENSTEIN U; WENISCH C; THALHAMMER F; LOOAREESUWAN S; GRANINGER W
    SERUM CONCENTRATIONS OF MIP-1-ALPHA AND INTERLEUKIN-8 IN PATIENTS SUFFERING FROM ACUTE PLASMODIUM-FALCIPARUM MALARIA
    Clinical immunology and immunopathology
    
    H. Burgmann et al., "SERUM CONCENTRATIONS OF MIP-1-ALPHA AND INTERLEUKIN-8 IN PATIENTS SUFFERING FROM ACUTE PLASMODIUM-FALCIPARUM MALARIA", Clinical immunology and immunopathology, 76(1), 1995, pp. 32-36
45. KREMSNER PG; ENYONG P; KRIJGER FW; DEJONGE N; ZOTTER GM; THALHAMMER F; MUHLSCHLEGEL F; BIENZLE U; FELDMEIER H; DEELDER AM
    CIRCULATING ANODIC AND CATHODIC ANTIGEN IN SERUM AND URINE FROM SCHISTOSOMA-HAEMATOBIUM - INFECTED CAMEROONIAN CHILDREN RECEIVING PRAZIQUANTEL - A LONGITUDINAL-STUDY
    Clinical infectious diseases
    
    P.G. Kremsner et al., "CIRCULATING ANODIC AND CATHODIC ANTIGEN IN SERUM AND URINE FROM SCHISTOSOMA-HAEMATOBIUM - INFECTED CAMEROONIAN CHILDREN RECEIVING PRAZIQUANTEL - A LONGITUDINAL-STUDY", Clinical infectious diseases, 18(3), 1994, pp. 408-413
46. THALHAMMER F; ROSENKRANZ AR; SCHENK P; SCHERRER R; BREYER S; TRAINDL O
    PHARMACOKINETICS OF TEICOPLANIN IN HEMODIALYSIS-PATIENTS WITH POLYSULFONE MEMBRANES
    Journal of the American Society of Nephrology
    
    F. Thalhammer et al., "PHARMACOKINETICS OF TEICOPLANIN IN HEMODIALYSIS-PATIENTS WITH POLYSULFONE MEMBRANES", Journal of the American Society of Nephrology, 5(3), 1994, pp. 480-480
47. ROSENKRANZ AR; THALHAMMER F; HOLUB M; NOVACEK G; TRAINDL O
    CALCITRIOL - DAILY ORAL OR INTRAVENOUS PULSE THERAPY
    Journal of the American Society of Nephrology
    
    A.R. Rosenkranz et al., "CALCITRIOL - DAILY ORAL OR INTRAVENOUS PULSE THERAPY", Journal of the American Society of Nephrology, 5(3), 1994, pp. 887-887
48. THALHAMMER F; GISSLINGER H; CHOTT A; HAAS O; ETELEHAINZ A; HELBICH T; KUSEC R; LINKESCH W; SIMONITSCH I; STROBL H; LECHNER K; JAGER U
    GRANULOCYTIC SARCOMA OF THE PROSTATE AS THE 1ST MANIFESTATION OF A LATE RELAPSE OF ACUTE MYELOGENOUS LEUKEMIA
    Annals of hematology
    
    F. Thalhammer et al., "GRANULOCYTIC SARCOMA OF THE PROSTATE AS THE 1ST MANIFESTATION OF A LATE RELAPSE OF ACUTE MYELOGENOUS LEUKEMIA", Annals of hematology, 68(2), 1994, pp. 97-99
49. PIRCDANOEWINATA H; CHOTT A; ONDERKA E; DRACH J; SCHLOGL E; JAGER U; THALHAMMER F; NOWOTNY H; ARYEE D; STEGER GG; LOCKER G; MICHL I; DJAVANMARD M; SIMONITSCH I; RADASZKIEWICZ T; HANAK H; SCHNEIDER B; HEINZ R; MAROSI C
    KARYOTYPE AND PROGNOSIS IN NON-HODGKIN-LYMPHOMA
    Leukemia
    
    H. Pircdanoewinata et al., "KARYOTYPE AND PROGNOSIS IN NON-HODGKIN-LYMPHOMA", Leukemia, 8(11), 1994, pp. 1929-1939
50. LACZIKA K; MITTERBAUER G; KORNINGER L; KNOBL P; SCHWARZINGER I; KAPIOTIS S; HAAS OA; KYRLE PA; PONT J; OEHLER L; PURTSCHER B; THALHAMMER F; LECHNER K; JAEGER U
    RAPID ACHIEVEMENT OF PML-RAR-ALPHA POLYMERASE CHAIN-REACTION (PCR)-NEGATIVITY BY COMBINED TREATMENT WITH ALL-TRANS-RETINOIC ACID AND CHEMOTHERAPY IN ACUTE PROMYELOCYTIC LEUKEMIA - A PILOT-STUDY
    Leukemia
    
    K. Laczika et al., "RAPID ACHIEVEMENT OF PML-RAR-ALPHA POLYMERASE CHAIN-REACTION (PCR)-NEGATIVITY BY COMBINED TREATMENT WITH ALL-TRANS-RETINOIC ACID AND CHEMOTHERAPY IN ACUTE PROMYELOCYTIC LEUKEMIA - A PILOT-STUDY", Leukemia, 8(1), 1994, pp. 1-5
51. GRANINGER W; PRADA J; NEIFER S; ZOTTER G; THALHAMMER F; KREMSNER PG
    UP-REGULATION OF ICAM-I BY PLASMODIUM-FALCIPARUM - IN-VITRO AND IN-VIVO STUDIES
    Journal of Clinical Pathology
    
    W. Graninger et al., "UP-REGULATION OF ICAM-I BY PLASMODIUM-FALCIPARUM - IN-VITRO AND IN-VIVO STUDIES", Journal of Clinical Pathology, 47(7), 1994, pp. 653-656
52. SCHERRER R; GEISSLER K; KYRLE PA; GISSLINGER H; JAGER U; BETTELHEIM P; LACZIKA K; LOCKER G; SCHOLTEN C; SILLABER C; SCHWARZINGER I; THALHAMMER F; LECHNER K
    GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AS AN ADJUNCT TO INDUCTION CHEMOTHERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    Annals of hematology
    
    R. Scherrer et al., "GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AS AN ADJUNCT TO INDUCTION CHEMOTHERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)", Annals of hematology, 66(6), 1993, pp. 283-289